SCHEMBL3499676

SCHEMBL3499676

CCOC(=O)C1(N)Cc2ccc(-c3ccc(F)cc3)cc2C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.43
MAPT P10636 3/20 0.41
KDM4E B2RXH2 2/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
NPSR1 Q6W5P4 2/20 0.39
MEN1 O00255 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2C19 P33261 2/20 0.39
KMT2A Q03164 2/20 0.39
FPR2 P25090 1/20 0.39
SCN9A Q15858 1/20 0.39
LMNA P02545 1/20 0.39
CYP2C9 P11712 1/20 0.39
TRPM8 Q7Z2W7 1/20 0.38
GRM6 O15303 1/20 0.38
PRKCZ Q05513 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3498275 0.90 OPRM1 (0.41) OPRM1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL3305558 0.89 OPRM1 (0.44) OPRM1MAPTNPSR1MEN1CYP1A2
SCHEMBL3498220 0.87 MEN1 (0.45) OPRM1MAPTNPC1RAB9AMEN1
Hydrochloric Acid SCHEMBL3498072 0.86 OPRM1 (0.45) OPRM1MAPTNPC1RAB9AMEN1
SCHEMBL3499819 0.85 TDP2 (0.44) OPRM1MEN1KMT2APTGS2
SCHEMBL3499699 0.85 AOC3 (0.42) MAPTKDM4ERAB9ASMN1; SMN2MEN1
SCHEMBL3498330 0.84 POLB (0.44) PTGS2
SCHEMBL3498052 0.81 CHEK2 (0.44) OPRM1MAPTKDM4EMEN1CYP1A2
Hydrochloric Acid SCHEMBL3498150 0.81 GRIA1 (0.41) OPRM1MAPTKDM4ENPC1RAB9A
SCHEMBL18664545 0.81 OPRM1 (0.42) OPRM1MAPTKDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100130737-A1 Regulating Agent of GPR34 Receptor Function TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-05-27 US disclosed
US-20100130737-A1 Regulating Agent of GPR34 Receptor Function TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-05-27 US disclosed
US-20100130737-A1 Regulating Agent of GPR34 Receptor Function TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-05-27 US disclosed
EP-1849465-A1 AGENT FOR CONTROLLING FUNCTION OF GPR34 RECEPTOR Takeda Pharmaceutical Company Limited (JP) 2007-10-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130737-A1 Regulating Agent of GPR34 Receptor Function GPR34, GPR4, GPR6 OPRM1 450/4885MAPT 4820/4885KDM4E 2059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.